VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Status:
RECRUITING
Trial end date:
2030-09-01
Target enrollment:
Participant gender:
Summary
The goal of this phase 1/2 trial is to test the safety and efficacy of Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT in treating patients with higher-risk MDS.